Qinotto, Inc.
PrivateLast Round
Grant
Dec 15, 2021
Total Funding Raised
$1M
Company Overview
Qinotto, Inc. is a biotechnology company that develops novel blood-brain barrier transport vehicles to deliver large molecule therapeutics to the brain.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Qinotto, Inc. Comparables
Compare Qinotto, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AbbVie | 81% | |
| Denali Therapeutics | 79% | |
| Gate2Brain | 79% | |
Qinotto, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 15, 2021 |
Qinotto, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Remiges Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 15, 2021
$1M grant received from Alzheimer's Association.
Qinotto, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Qinotto, Inc.'s valuation, stock price, and market status.